서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 36 of 36

Issue DateTitle / Author(s) / CitationFileAltmetrics
2004-05
An Immunohistochemical Study of the Expression of Adhesion Molecules in Gallbladder Lesions
DOI
2005-05
Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors
DOI
2005-05
HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors
DOI
2005-05
Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors
link
2005-10
The neurological safety of epidural gabapentin in rats: a light microscopic examination
link
2006-08
Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions
DOI
2007-01
Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression
DOI
2007-01
Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression
DOI
2007-05
Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma
DOI
2007-05
Clinical significance of CD99 down-regulation in gastric adenocarcinoma
link
2007-05
Clinical significance of CD99 down-regulation in gastric adenocarcinoma
DOI
2009-05
Expression of Sonic hedgehog signaling molecules in normal,hyperplastic and carcinomatous endometrium
DOI
2010-03
LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer
DOI
2010-06
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
DOI
2010-09
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
view fileDOI
2010-09
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
view fileDOI
2010-09
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
view fileDOI
2011-01
Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
view fileDOI
2011-03
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: Pathological implication in tumorigenesis
view fileDOI
2011-11
Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma
DOI
2012-04
The synergistic therapeutic effect of cisplatin with Human Papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo
DOI
2012-04
A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity

Oh, Ensel; Choi, Yoon-La; Park, Taesung; Lee, Seungyeoun; Nam, Seok Jin; Shin, Young Kee

Breast Cancer Research and Treatment; Vol.132, No.2; pp. 499-509

DOI
2012-05
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
DOI
2013-01
Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer
DOI
2015-08
Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small-cell lung cancer: KCSG-LU05-04
DOI
2017-05
Molecular Testing of Lung Cancers
DOI
2019-11
High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy
view filelink
2020-08
Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung Adenocarcinoma
DOI
2021-12
NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions
DOI
2022-04
Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling
DOI
2022-06
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
DOI
2022-09
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
DOI
2023-07
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
DOI
2023-07
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
view fileDOI
2024-01
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
view fileDOI
2024-02
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
DOI
1